A Single Dose, 4-Period, 2-Treatment Replicate Design Bioequivalency Study of Granisetron Hydrochloride 1 mg Tablets Under Fasting Conditions

NCT00618254 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Nausea
Vomiting

Interventions

DRUG: Granisetron

Sponsor

Roxane Laboratories